Management of Rare Breast Tumors and Male Breast Cancer

被引：0
作者：
Euhus D.M. [1 ]
机构：
[1] Johns Hopkins University, Blalock 688, 600 N. Wolfe St, Baltimore, 21287, MD
来源：
Current Breast Cancer Reports | 2017年 / 9卷 / 2期
关键词：
Breast neoplasms; Encapsulated papillary carcinoma; Implant-associated anaplastic large cell lymphoma; Male breast cancer; Metaplastic breast cancer; Neuroendocrine differentiation; Phyllodes tumor; Radiation-associated angiosarcoma;
D O I：
10.1007/s12609-017-0243-x
中图分类号：
学科分类号：
摘要：
Purpose of Review: There is very little clinical trial data available to guide the management of uncommon breast cancers. This review draws on classic and recent retrospective data to synthesize a clearer understanding of the biology and behavior of these rare tumors. Recent Findings: Avoid disfiguring surgery in the pursuit of very wide margins for benign phyllodes tumors unless there are adverse histological features. Encapsulated papillary carcinoma is very good prognosis breast cancer; do not over treat. Metaplastic carcinoma is a basal type breast cancer that may be more responsive to “BRCA1-like” treatments. Complete excision of the capsule is curative for most implant-associated anaplastic large cell lymphomas. Aromatase inhibitors are still controversial for male breast cancer; tamoxifen is standard. Summary: Available data are useful for guiding the treatment of rare breast cancers, but it must be recognized that there is still a great deal to be learned about each of these entities. © 2017, Springer Science+Business Media New York.
引用
收藏
页码：156 / 164
页数：8
相关论文
共 78 条
[11]  
Kim S., Kim J.Y., Analysis of phyllodes tumor recurrence according to the histologic grade, Breast Cancer Res Treat, 141, 3, pp. 353-363, (2013)
[12]  
Barrio A.V., Clark B.D., Goldberg J.I., Hoque L.W., Bernik S.F., Flynn L.W., Et al., Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast, Ann Surg Oncol, 14, 10, pp. 2961-2970, (2007)
[13]  
Cheng S.P., Chang Y.C., Liu T.P., Lee J.J., Tzen C.Y., Liu C.L., Phyllodes tumor of the breast: the challenge persists, World J Surg, 30, 8, pp. 1414-1421, (2006)
[14]  
Borhani-Khomani K., Talman M.L., Kroman N., Tvedskov T.F., Risk of local recurrence of benign and borderline phyllodes tumors: a Danish population-based retrospective study, Ann Surg Oncol, 23, 5, pp. 1543-1548, (2016)
[15]  
Yom C.K., Han W., Kim S.W., Park S.Y., Park I.A., Noh D.Y., Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast, Ann Surg Oncol, 22, 9, pp. 2912-2918, (2015)
[16]  
Mitus J.W., Blecharz P., Walasek T., Reinfuss M., Jakubowicz J., Kulpa J., Treatment of patients with distant metastases from phyllodes tumor of the breast, World J Surg, 40, 2, pp. 323-328, (2016)
[17]  
Barth R.J., Wells W.A., Mitchell S.E., Cole B.F., A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors, Ann Surg Oncol, 16, 8, pp. 2288-2294, (2009)
[18]  
Belkacemi Y., Bousquet G., Marsiglia H., Ray-Coquard I., Magne N., Malard Y., Et al., Phyllodes tumor of the breast, Int J Radiat Oncol Biol Phys, 70, 2, pp. 492-500, (2008)
[19]  
Rakha E.A., Gandhi N., Climent F., van Deurzen C.H., Haider S.A., Dunk L., Et al., Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis, Am J Surg Pathol, 35, 8, pp. 1093-1103, (2011)
[20]  
Esposito N.N., Dabbs D.J., Bhargava R., Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases, Am J Clin Pathol, 131, 2, pp. 228-242, (2009)
12345678